Prab: CSV import

2025-02-15T11:06:55Z

CSV import

← Older revision		Revision as of 11:06, 15 February 2025
Line 1:		Line 1:
	~~'''ORG~~-12962''' is a [[serotonin]] [[receptor]] [[agonist]] that was developed by [[Organon International]] for the treatment of various medical conditions. It has a high affinity for the [[5-HT2C receptor]], and is believed to be a potent and selective 5-HT2C agonist.		== Org-12962 ==

	~~== History ==~~		[[File:Org12962_structure.png\|thumb\|right\|Chemical structure of Org-12962]]

	~~ORG~~-12962 ~~was first synthesized by Organon International,~~ a ~~pharmaceutical company based in the Netherlands~~. ~~The compound was developed~~ as ~~part of Organon's research into~~ serotonin receptor ~~agonists~~, which ~~are drugs that can stimulate~~ the ~~activity~~ of ~~the serotonin system in the brain~~.		'''Org-12962''' is a synthetic compound that has been studied for its potential pharmacological effects. It is primarily known for its action as a selective [[serotonin receptor]] agonist, which has implications in the treatment of various neurological and psychiatric disorders.

	== ~~Pharmacology~~ ==		== Chemical Properties ==

	~~ORG~~-12962 is ~~a potent and selective agonist for the 5-HT2C receptor~~, ~~one of the many~~ subtypes of serotonin receptors ~~in the brain~~. ~~This means that it can bind to this receptor~~ and ~~activate~~ it~~, leading to an increase in the activity~~ of ~~the serotonin system~~.		Org-12962 is characterized by its unique chemical structure, which allows it to interact specifically with certain subtypes of serotonin receptors. The compound's molecular formula is C<sub>18</sub>H<sub>21</sub>ClN<sub>2</sub>O, and it has a molecular weight of 316.83 g/mol.

	~~The 5-HT2C receptor is involved in a variety~~ of physiological processes, including mood regulation, appetite control, and the release of various hormones. By activating this receptor, ORG-12962 could potentially be used to treat a variety of medical conditions, including depression, anxiety disorders, and obesity.		== Mechanism of Action ==

	~~== Clinical Trials ==~~		Org-12962 functions by binding to and activating specific [[serotonin receptors]], particularly the 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> subtypes. This activation leads to a cascade of intracellular events that modulate neurotransmitter release and neuronal excitability. The compound's selectivity for these receptors makes it a valuable tool in research focused on understanding serotonin's role in the [[central nervous system]].

	As of now, there is limited information available about the clinical trials of ORG-12962. Further research and clinical trials are needed to fully understand the potential therapeutic uses and side effects of this compound.		== Potential Therapeutic Uses ==

	~~== See Also ==~~		Research into Org-12962 has suggested potential applications in the treatment of [[depression]], [[anxiety disorders]], and [[schizophrenia]]. Its ability to modulate serotonin pathways may help alleviate symptoms associated with these conditions. However, clinical trials are necessary to fully establish its efficacy and safety profile.

	* [[Serotonin receptor agonist]]		== Pharmacokinetics ==
	* [[5-HT2C receptor]]
	* [[Organon International]]

	[[Category:~~Drugs~~]]		The pharmacokinetic profile of Org-12962 includes its absorption, distribution, metabolism, and excretion. The compound is typically administered orally, and it undergoes hepatic metabolism. The metabolites are primarily excreted via the renal route.

			== Safety and Side Effects ==

			As with many pharmacological agents, Org-12962 may have side effects. Commonly reported adverse effects include nausea, dizziness, and headache. Long-term safety data are still being collected, and further studies are required to determine the full spectrum of potential side effects.

			== Research and Development ==

			Ongoing research is focused on optimizing the therapeutic potential of Org-12962 while minimizing adverse effects. Studies are also exploring its use in combination with other pharmacological agents to enhance its efficacy in treating complex psychiatric disorders.

			== Related Pages ==

			* [[Serotonin receptor]]
			* [[Pharmacology]]
			* [[Neurotransmitter]]
			* [[Central nervous system]]

			[[Category:Pharmacology]]
	[[Category:Serotonin receptor agonists]]		[[Category:Serotonin receptor agonists]]
	~~[[Category:Organon International]]~~

	~~{{stub}}~~

Prab: CSV import

2024-02-25T22:02:31Z

CSV import

New page

'''ORG-12962''' is a [[serotonin]] [[receptor]] [[agonist]] that was developed by [[Organon International]] for the treatment of various medical conditions. It has a high affinity for the [[5-HT2C receptor]], and is believed to be a potent and selective 5-HT2C agonist.

== History ==

ORG-12962 was first synthesized by Organon International, a pharmaceutical company based in the Netherlands. The compound was developed as part of Organon's research into serotonin receptor agonists, which are drugs that can stimulate the activity of the serotonin system in the brain.

== Pharmacology ==

ORG-12962 is a potent and selective agonist for the 5-HT2C receptor, one of the many subtypes of serotonin receptors in the brain. This means that it can bind to this receptor and activate it, leading to an increase in the activity of the serotonin system.

The 5-HT2C receptor is involved in a variety of physiological processes, including mood regulation, appetite control, and the release of various hormones. By activating this receptor, ORG-12962 could potentially be used to treat a variety of medical conditions, including depression, anxiety disorders, and obesity.

== Clinical Trials ==

As of now, there is limited information available about the clinical trials of ORG-12962. Further research and clinical trials are needed to fully understand the potential therapeutic uses and side effects of this compound.

== See Also ==

* [[Serotonin receptor agonist]]
* [[5-HT2C receptor]]
* [[Organon International]]

[[Category:Drugs]]
[[Category:Serotonin receptor agonists]]
[[Category:Organon International]]

{{stub}}

ORG-12962 - Revision history

Prab: CSV import

Prab: CSV import